摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-([2-(4-chlorophenyl)-2-oxoethyl]sulfanyl)-4-(3-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile | 1233536-81-6

中文名称
——
中文别名
——
英文名称
2-([2-(4-chlorophenyl)-2-oxoethyl]sulfanyl)-4-(3-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile
英文别名
2-{[2-(4-Chlorophenyl)-2-oxoethyl]sulfanyl}-4-(3-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile;2-[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl-4-thiophen-3-yl-5,6,7,8-tetrahydroquinoline-3-carbonitrile
2-([2-(4-chlorophenyl)-2-oxoethyl]sulfanyl)-4-(3-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile化学式
CAS
1233536-81-6
化学式
C22H17ClN2OS2
mdl
——
分子量
424.975
InChiKey
QQDBKMMYZYHGKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    107
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    4-(3-thienyl)-2-thioxo-1,2,5,6,7,8-hexahydroquinoline-3-carbonitrile 、 2'-溴-4-氯苯乙酮 在 potassium hydroxide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 0.5h, 以66%的产率得到2-([2-(4-chlorophenyl)-2-oxoethyl]sulfanyl)-4-(3-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile
    参考文献:
    名称:
    Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold
    摘要:
    In an approach to optimize 2-(4-fluorobenzylsulfanyl)-4-(2-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile (1a), a weak inhibitor of the cancer-related tyrosine kinase RET originating from a screening campaign, analogues with 3-thienyl substitution were prepared. Among the novel derivatives, 2-amino-6-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}-4-(3-thienyl)pyridine-3,5-dicarbonitrile (13g) was identified as a submicromolar RET inhibitor, displaying 3- and 100-fold selectivity versus ALK and ABL kinases, respectively. The novel inhibitor exhibited antiproliferative activity in the micromolar concentration range against both RET-dependent and RET-independent cancer cell lines. Docking experiments suggest a binding mode of the new inhibitors in the ATP binding pocket of the target kinase, explaining the observed structure activity relationships. (c) 2010 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2010.03.017
点击查看最新优质反应信息

文献信息

  • Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold
    作者:Wiebke Brandt、Luca Mologni、Lutz Preu、Thomas Lemcke、Carlo Gambacorti-Passerini、Conrad Kunick
    DOI:10.1016/j.ejmech.2010.03.017
    日期:2010.7
    In an approach to optimize 2-(4-fluorobenzylsulfanyl)-4-(2-thienyl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile (1a), a weak inhibitor of the cancer-related tyrosine kinase RET originating from a screening campaign, analogues with 3-thienyl substitution were prepared. Among the novel derivatives, 2-amino-6-[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}-4-(3-thienyl)pyridine-3,5-dicarbonitrile (13g) was identified as a submicromolar RET inhibitor, displaying 3- and 100-fold selectivity versus ALK and ABL kinases, respectively. The novel inhibitor exhibited antiproliferative activity in the micromolar concentration range against both RET-dependent and RET-independent cancer cell lines. Docking experiments suggest a binding mode of the new inhibitors in the ATP binding pocket of the target kinase, explaining the observed structure activity relationships. (c) 2010 Elsevier Masson SAS. All rights reserved.
查看更多